166 related articles for article (PubMed ID: 38693172)
1. Forecasting the spread of COVID-19 based on policy, vaccination, and Omicron data.
Han K; Lee B; Lee D; Heo G; Oh J; Lee S; Apio C; Park T
Sci Rep; 2024 Apr; 14(1):9962. PubMed ID: 38693172
[TBL] [Abstract][Full Text] [Related]
2. Real-time forecasting of COVID-19 spread according to protective behavior and vaccination: autoregressive integrated moving average models.
Cheng C; Jiang WM; Fan B; Cheng YC; Hsu YT; Wu HY; Chang HH; Tsou HH
BMC Public Health; 2023 Aug; 23(1):1500. PubMed ID: 37553650
[TBL] [Abstract][Full Text] [Related]
3. A COVID-19 Pandemic Artificial Intelligence-Based System With Deep Learning Forecasting and Automatic Statistical Data Acquisition: Development and Implementation Study.
Yu CS; Chang SS; Chang TH; Wu JL; Lin YJ; Chien HF; Chen RJ
J Med Internet Res; 2021 May; 23(5):e27806. PubMed ID: 33900932
[TBL] [Abstract][Full Text] [Related]
4. Prediction of global omicron pandemic using ARIMA, MLR, and Prophet models.
Zhao D; Zhang R; Zhang H; He S
Sci Rep; 2022 Oct; 12(1):18138. PubMed ID: 36307471
[TBL] [Abstract][Full Text] [Related]
5. COVID-19 Cases and Hospitalizations by COVID-19 Vaccination Status and Previous COVID-19 Diagnosis - California and New York, May-November 2021.
León TM; Dorabawila V; Nelson L; Lutterloh E; Bauer UE; Backenson B; Bassett MT; Henry H; Bregman B; Midgley CM; Myers JF; Plumb ID; Reese HE; Zhao R; Briggs-Hagen M; Hoefer D; Watt JP; Silk BJ; Jain S; Rosenberg ES
MMWR Morb Mortal Wkly Rep; 2022 Jan; 71(4):125-131. PubMed ID: 35085222
[TBL] [Abstract][Full Text] [Related]
6. Forecasting daily new infections, deaths and recovery cases due to COVID-19 in Pakistan by using Bayesian Dynamic Linear Models.
Khan F; Ali S; Saeed A; Kumar R; Khan AW
PLoS One; 2021; 16(6):e0253367. PubMed ID: 34138956
[TBL] [Abstract][Full Text] [Related]
7. Trends in Disease Severity and Health Care Utilization During the Early Omicron Variant Period Compared with Previous SARS-CoV-2 High Transmission Periods - United States, December 2020-January 2022.
Iuliano AD; Brunkard JM; Boehmer TK; Peterson E; Adjei S; Binder AM; Cobb S; Graff P; Hidalgo P; Panaggio MJ; Rainey JJ; Rao P; Soetebier K; Wacaster S; Ai C; Gupta V; Molinari NM; Ritchey MD
MMWR Morb Mortal Wkly Rep; 2022 Jan; 71(4):146-152. PubMed ID: 35085225
[TBL] [Abstract][Full Text] [Related]
8. SARS-CoV-2 Infection and Hospitalization Among Adults Aged ≥18 Years, by Vaccination Status, Before and During SARS-CoV-2 B.1.1.529 (Omicron) Variant Predominance - Los Angeles County, California, November 7, 2021-January 8, 2022.
Danza P; Koo TH; Haddix M; Fisher R; Traub E; OYong K; Balter S
MMWR Morb Mortal Wkly Rep; 2022 Feb; 71(5):177-181. PubMed ID: 35113851
[TBL] [Abstract][Full Text] [Related]
9. Development and evaluation of a machine learning-based in-hospital COVID-19 disease outcome predictor (CODOP): A multicontinental retrospective study.
Klén R; Purohit D; Gómez-Huelgas R; Casas-Rojo JM; Antón-Santos JM; Núñez-Cortés JM; Lumbreras C; Ramos-Rincón JM; García Barrio N; Pedrera-Jiménez M; Lalueza Blanco A; Martin-Escalante MD; Rivas-Ruiz F; Onieva-García MÁ; Young P; Ramirez JI; Titto Omonte EE; Gross Artega R; Canales Beltrán MT; Valdez PR; Pugliese F; Castagna R; Huespe IA; Boietti B; Pollan JA; Funke N; Leiding B; Gómez-Varela D
Elife; 2022 May; 11():. PubMed ID: 35579324
[TBL] [Abstract][Full Text] [Related]
10. Advanced forecasting of COVID-19 epidemic: Leveraging ensemble models, advanced optimization, and decomposition techniques.
Yin Y; Ahmadianfar I; Karim FK; Elmannai H
Comput Biol Med; 2024 Jun; 175():108442. PubMed ID: 38678939
[TBL] [Abstract][Full Text] [Related]
11. A proficient approach to forecast COVID-19 spread via optimized dynamic machine learning models.
Alali Y; Harrou F; Sun Y
Sci Rep; 2022 Feb; 12(1):2467. PubMed ID: 35165290
[TBL] [Abstract][Full Text] [Related]
12. Epidemiological characteristics of 17 imported patients infected with SARS-CoV-2 Omicron variant.
Liu X; Chen M; Zhou Z; Chen D; Mo J; Liu J
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2022 Mar; 47(3):344-351. PubMed ID: 35545327
[TBL] [Abstract][Full Text] [Related]
13. Forecasting daily confirmed COVID-19 cases in Malaysia using ARIMA models.
Singh S; Murali Sundram B; Rajendran K; Boon Law K; Aris T; Ibrahim H; Chandra Dass S; Singh Gill B
J Infect Dev Ctries; 2020 Sep; 14(9):971-976. PubMed ID: 33031083
[TBL] [Abstract][Full Text] [Related]
14. Disease severity and efficacy of homologous vaccination among patients infected with SARS-CoV-2 Delta or Omicron VOCs, compared to unvaccinated using main biomarkers.
Ali AM; Tofiq AM; Rostam HM; Ali KM; Tawfeeq HM
J Med Virol; 2022 Dec; 94(12):5867-5876. PubMed ID: 36029103
[TBL] [Abstract][Full Text] [Related]
15. COVID-19-Associated Hospitalizations Among Adults During SARS-CoV-2 Delta and Omicron Variant Predominance, by Race/Ethnicity and Vaccination Status - COVID-NET, 14 States, July 2021-January 2022.
Taylor CA; Whitaker M; Anglin O; Milucky J; Patel K; Pham H; Chai SJ; Alden NB; Yousey-Hindes K; Anderson EJ; Teno K; Reeg L; Como-Sabetti K; Bleecker M; Barney G; Bennett NM; Billing LM; Sutton M; Talbot HK; McCaffrey K; Havers FP;
MMWR Morb Mortal Wkly Rep; 2022 Mar; 71(12):466-473. PubMed ID: 35324880
[TBL] [Abstract][Full Text] [Related]
16. Clinical Characteristics and Outcomes Among Adults Hospitalized with Laboratory-Confirmed SARS-CoV-2 Infection During Periods of B.1.617.2 (Delta) and B.1.1.529 (Omicron) Variant Predominance - One Hospital, California, July 15-September 23, 2021, and December 21, 2021-January 27, 2022.
Modes ME; Directo MP; Melgar M; Johnson LR; Yang H; Chaudhary P; Bartolini S; Kho N; Noble PW; Isonaka S; Chen P
MMWR Morb Mortal Wkly Rep; 2022 Feb; 71(6):217-223. PubMed ID: 35143466
[TBL] [Abstract][Full Text] [Related]
17. A New Auto-Regressive Multi-Variable Modified Auto-Encoder for Multivariate Time-Series Prediction: A Case Study with Application to COVID-19 Pandemics.
de Oliveira EV; Aragão DP; Gonçalves LMG
Int J Environ Res Public Health; 2024 Apr; 21(4):. PubMed ID: 38673408
[TBL] [Abstract][Full Text] [Related]
18. Identifying susceptibility of children and adolescents to the Omicron variant (B.1.1.529).
Chun JY; Jeong H; Kim Y
BMC Med; 2022 Nov; 20(1):451. PubMed ID: 36419108
[TBL] [Abstract][Full Text] [Related]
19. Vaccine effectiveness against SARS-CoV-2 reinfection during periods of Alpha, Delta, or Omicron dominance: A Danish nationwide study.
Nielsen KF; Moustsen-Helms IR; Schelde AB; Gram MA; Emborg HD; Nielsen J; Hansen CH; Andersen MA; Meaidi M; Wohlfahrt J; Valentiner-Branth P
PLoS Med; 2022 Nov; 19(11):e1004037. PubMed ID: 36413551
[TBL] [Abstract][Full Text] [Related]
20. Editorial: The 2022 World Health Organization (WHO) Priority Recommendations and Response to the Omicron Variant (B.1.1.529) of SARS-CoV-2.
Parums DV
Med Sci Monit; 2022 Feb; 28():e936199. PubMed ID: 35102132
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
